|
(PQC2) Resistance to fluid shear stress: a novel biomarker of cancer cells
|
1R21CA179981-01
|
$197,055
|
Henry, Michael
|
UNIVERSITY OF IOWA
|
|
A comparison of interventions to teach melanoma patients' skin self-examination
|
5R01CA154908-03
|
$501,257
|
ROBINSON, JUNE
|
NORTHWESTERN UNIVERSITY AT CHICAGO
|
|
A High-Throughput Model for Human Melanoma
|
3R01CA121118-05S1
|
$59,552
|
Holmen, Sheri
|
UNIVERSITY OF UTAH
|
|
A new approach to identify rare genetic variants influencing melanoma risk
|
4R03CA156624-02
|
$54,144
|
Lesueur, Fabienne
|
INTERNATIONAL AGENCY FOR RES ON CANCER
|
|
A novel NKG2D-specific BiTE cancer immunotherapy
|
1R01CA164178-01A1
|
$335,113
|
Sentman, Charles
|
DARTMOUTH COLLEGE
|
|
A novel preclinical model of spontaneous metastasis
|
ZIA BC 011167
|
$352,646
|
Merlino, Glenn
|
CCR (NCI)
|
|
A NOVEL STRATEGY FOR THE TREATMENT OF MELANOMA
|
1R03CA175660-01
|
$66,120
|
Xu, Mai
|
WASHINGTON UNIVERSITY
|
|
A Patient Oriented Research Program for Surgical Oncologists
|
7K24CA138709-04
|
$114,822
|
GOYDOS, JAMES
|
RBHS -CANCER INSTITUTE OF NEW JERSEY
|
|
A research and training program for junior clinicians in treating metastatic mela
|
1K24CA172123-01A1
|
$156,084
|
Kluger, Harriet
|
YALE UNIVERSITY
|
|
A role for c-Abl/Arg in melanoma progression
|
5R01CA166499-02
|
$294,962
|
PLATTNER, RINA
|
UNIVERSITY OF KENTUCKY
|
|
A Small Molecule to Activate Tumor Immunity after PLX403 in V600E BRAF Melanoma
|
1R41CA174008-01A1
|
$232,852
|
Jones, Barry
|
ARISAPH PHARMACEUTICALS, INC.
|
|
Abramson Cancer Center Support Grant
|
3P30CA016520-37S2
|
$12,499
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Abramson Cancer Center Support Grant
|
5P30CA016520-37
|
$7,216,850
|
DANG, CHI
|
UNIVERSITY OF PENNSYLVANIA
|
|
Accuracy in the Diagnosis of Melanoma & the Impact of Double Reading
|
5R01CA151306-03
|
$782,575
|
ELMORE, JOANN
|
UNIVERSITY OF WASHINGTON
|
|
ACOSOG Community Clinical Oncology Program (CCOP) Research Base
|
5U10CA149950-03
|
$1,055,550
|
Sloan, Jeff
|
MAYO CLINIC ROCHESTER
|
|
Addressing Undruggable Targets Using Oligonucleotides and Small Molecules (PQ18)
|
5R21CA170332-02
|
$155,382
|
JULIANO, RUDOLPH
|
UNIV OF NORTH CAROLINA CHAPEL HILL
|
|
Adoptive Cell Transfer Immunotherapy of Cancer
|
ZIA BC 010984
|
$1,602,394
|
Rosenberg, Steven
|
CCR (NCI)
|
|
Adoptive T cell Therapy of Melanoma Targeting NY-ESO-1
|
7R01CA104711-09
|
$291,580
|
Yee, Cassian
|
UT MD ANDERSON CANCER CTR
|
|
Advanced Development of TIES-Enhancing Access to Tissue for Cancer Research
|
1U24CA180921-01
|
$686,990
|
CROWLEY, REBECCA
|
UNIVERSITY OF PITTSBURGH
|
|
Advancing Clinical Trails in Coastal North Carolina
|
1U10CA176852-01
|
$532,663
|
MAGUIRE, PATRICK
|
NEW HANOVER REGIONAL MEDICAL CENTER
|
|
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
|
3R01CA134891-04S1
|
$28,066
|
HILLHOUSE, JOEL
|
EAST TENNESSEE STATE UNIVERSITY
|
|
An Appearance-Based Intervention to Reduce Teen Skin Cancer Risk
|
5R01CA134891-04
|
$536,383
|
HILLHOUSE, JOEL
|
EAST TENNESSEE STATE UNIVERSITY
|
|
An Immune Repertoire Deep Sequencing Companion Diagnostic for lpilimumab
|
N43CA130037-000
|
$266,199
|
RIEDER, MARK
|
ADAPTIVE BIOTECHNOLOGIES CORPORATION
|
|
An innovative, curriculum-based integrated sun exposure behavior intervention for
|
5R01CA158407-02
|
$645,278
|
COCKBURN, MYLES
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Analysis of cap-dependent translational repression by microRNAs in oncogensis
|
5R01CA140986-03
|
$307,204
|
NOVINA, CARL
|
DANA-FARBER CANCER INST
|
|
Analysis of the Signaling and Mechanical Cues Promoting Invasion in Melanoma
|
5U01CA155758-03
|
$320,753
|
LEVCHENKO, Andre
|
JOHNS HOPKINS UNIVERSITY
|
|
Animal Model and Genotyping Core Support Facility
|
ZIC BC 011047
|
$1,107,800
|
DuBois, Wendy
|
CCR (NCI)
|
|
Anticancer Strategies Targeting the Autotaxin-LPA Receptor Axis
|
5R01CA092160-12
|
$284,228
|
TIGYI, GABOR
|
UNIVERSITY OF TENNESSEE HEALTH SCI CTR
|
|
Antigen-specific T-cell Activation, Application to Vaccines for Cancer and AIDS
|
ZIA SC 004020
|
$2,557,725
|
Berzofsky, Jay
|
CCR (NCI)
|
|
Arginase Production in Cancer: Evading Immune Response
|
5R01CA107974-08
|
$276,975
|
OCHOA, AUGUSTO
|
LSU HEALTH SCIENCES CENTER
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
3P30CA023074-35S1
|
$75,000
|
Alberts, David
|
UNIVERSITY OF ARIZONA
|
|
Arizona Cancer Center-Cancer Center Support Grant
|
5P30CA023074-35
|
$3,676,771
|
CRESS, ANNE
|
UNIVERSITY OF ARIZONA
|
|
Artificial Immune Moduating (AIM??)Platform for the Treatment of Cancer
|
1R43CA177009-01
|
$288,268
|
MCCREEDY, BRUCE
|
NEXIMMUNE, INC.
|
|
Assessing Resident Physician Melanoma Detection Across Ethnic Groups
|
1R21CA176534-01
|
$205,481
|
Hernandez, Claudia
|
UNIVERSITY OF ILLINOIS
|
|
ATF2 Oncogenic Addiction in Melanoma
|
1R01CA172017-01A1
|
$404,625
|
RONAI, ZE'EV
|
SANFORD-BURNHAM MEDICAL RESEARCH INSTIT
|
|
B-RAF Regulation of the Cell Cycle in Melanoma
|
3R01CA125103-06S1
|
$58,707
|
Aplin, Andrew
|
THOMAS JEFFERSON UNIVERSITY
|
|
B7-H1 Signaling in Ovarian Cancer
|
5R01CA164122-02
|
$291,600
|
Curiel, Tyler
|
UNIV OF TX HSC, SA
|
|
B7-H1/PD-1 modulation in cancer therapy
|
5R01CA142779-04
|
$437,199
|
PARDOLL, DREW
|
JOHNS HOPKINS UNIVERSITY
|
|
Bacterial Minicells for Cancer Therapeutics
|
1F32CA165657-01A1
|
$52,190
|
Danino, Tal
|
MASSACHUSETTS INSTITUTE OF TECHNOLOGY
|
|
Basic and Preclinical Animal Models in support of Cancer and HIV/AIDS Research
|
ZIG BC 010856
|
$14,465,171
|
Custer, Mary
|
CCR (NCI)
|
|
Bay Area Tumor Institute CCOP
|
5U10CA045461-24
|
$486,165
|
Feusner, James
|
BAY AREA TUMOR INSTITUTE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S1
|
$75,000
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
3P30CA125123-07S2
|
$43,265
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Baylor College of Medicine Cancer Center
|
5P30CA125123-07
|
$3,092,811
|
OSBORNE, C
|
BAYLOR COLLEGE OF MEDICINE
|
|
Beaumont Community Clinical Oncology Program
|
3U10CA095860-12S1
|
$125,000
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Beaumont Community Clinical Oncology Program
|
5U10CA095860-12
|
$692,608
|
Robertson, John
|
WILLIAM BEAUMONT HOSPITAL RESEARCH INST
|
|
Biochemistry of Melanins and Photoprotection of the Skin
|
ZIA BC 010784
|
$253,078
|
Hearing, Vincent
|
CCR (NCI)
|
|
Biological Implications and Translational Applications of HDMX Inhibition
|
ZIA BC 011261
|
$51,885
|
Bernal, Federico
|
CCR (NCI)
|
|
Biology of Melanoma Metastasis
|
5R01CA047159-22
|
$288,936
|
HERLYN, MEENHARD
|
WISTAR INSTITUTE
|
|
BLIMP-1 mediated regulation of CD8+ TIL
|
1R01CA166458-01A1
|
$306,001
|
BULLOCK, TIMOTHY
|
UNIVERSITY OF VIRGINIA
|
Relevant funding data is only available when one cancer type or one research topic is selected.
|